Odisha News, Odisha Latest news, Odisha Daily - OrissaPOST
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
No Result
View All Result
OrissaPOST - Odisha Latest news, English Daily -
No Result
View All Result

New oral vaccine for diarrhoea found safe in clinical trials

IANS
Updated: November 21st, 2019, 22:28 IST
in Feature
0
Share on FacebookShare on TwitterShare on WhatsAppShare on Linkedin

An oral, inactivated vaccine candidate against enterotoxigenic E. coli diarrohea has been found safe for infants and children in a clinical trial conducted in Bangladesh.

Enterotoxigenic E. coli (ETEC) bacteria are a primary cause of diarrohea, leading to substantial illness and death in children in low- and middle-income countries (LMICs) as well as in travellers to these countries.

Also Read

Viral video

Watch viral video: Yamraj’s niece? Girl hugs terrifying beast; what happens next will stun you

10 hours ago
Viral video

Watch viral video: Pakistani MP takes India’s name in Parliament, what he says leaves everyone shocked

11 hours ago

Currently, there is no ETEC vaccine available on the market for use in either children or travellers to ETEC high-risk areas, and ETEC vaccine development is a World Health Organization priority.

The findings published in the journal The Lancet Infectious Diseases showed that all predefined primary endpoints for the study were achieved, showing that the vaccine candidate was safe and broadly immunogenic, stimulating immune responses to all key vaccine components.

The oral ETEC vaccine candidate, ETVAX, was developed at Sweden’s University of Gothenburg in collaboration with Scandinavian Biopharma, Stockholm.

ETVAX consists of inactivated E. coli bacteria expressing high levels of protective antigens and the ETEC-based B subunit protein LCTBA.

This clinical study examined the administration of ETVAX, given alone or together with different doses of an adjuvant, double-mutant heat-labile toxin (dmLT), to assess the vaccine’s safety and immunogenicity in 450 children.

The study involved infants and children from 6 months to 5 years of age.

In addition to safety analyses, immune responses were determined by measuring the amount of antibodies produced in the intestine (feces) as well as antibodies secreted by lymphocytes circulating in blood to the intestine.

The results confirm and extend the promising data previously reported from ETVAX trials in Swedish and Bangladeshi adults, said the study.

Tags: Clinical trialDiarrhoeavaccine
ShareTweetSendShare
Suggest A Correction

Enter your email to get our daily news in your inbox.

IEC (1yr.)

 

OrissaPOST epaper Sunday POST OrissaPOST epaper

Click Here: Plastic Free Odisha

#MyPaperBagChallenge

Adweeti Bhattacharya

December 12, 2019
#MyPaperBagChallenge

Bijswajit Pradhan

December 12, 2019
#MyPaperBagChallenge

Keshab Chandra Rout

December 12, 2019
#MyPaperBagChallenge

Ramakanta Sahoo

December 12, 2019
#MyPaperBagChallenge

Amritansh Mishra

December 12, 2019
#MyPaperBagChallenge

Ipsita

December 12, 2019
#MyPaperBagChallenge

Ramakanta Sahoo

December 12, 2019
#MyPaperBagChallenge

Archit Mohapatra

December 12, 2019
#MyPaperBagChallenge

Mrutyunjaya Behera

December 12, 2019
#MyPaperBagChallenge

Debasis Mohanty

December 12, 2019
#MyPaperBagChallenge

Arya Ayushman

December 12, 2019
#MyPaperBagChallenge

Akshaya Kumar Dash

December 12, 2019
#MyPaperBagChallenge

Aishwarya Ranjan Mohanty

December 12, 2019
#MyPaperBagChallenge

Adrita Bhattacharya

December 12, 2019
#MyPaperBagChallenge

Diptiranjan Biswal

December 12, 2019
#MyPaperBagChallenge

Sibarama Khotei

December 12, 2019
#MyPaperBagChallenge

Akriti Negi

December 12, 2019
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
#MyPaperBagChallenge

Dibya Ranjan Das

December 12, 2019
#MyPaperBagChallenge

Archana Parida

December 12, 2019
#MyPaperBagChallenge

Tabish Maaz

December 12, 2019
#MyPaperBagChallenge

Sarfraz Ahmad

December 12, 2019
#MyPaperBagChallenge

Ankita Balabantray

December 12, 2019
#MyPaperBagChallenge

Subhajyoti Mohanty

December 12, 2019
#MyPaperBagChallenge

Pitabas Tripathy

December 12, 2019
#MyPaperBagChallenge

Praptimayee Biswal

December 12, 2019
#MyPaperBagChallenge

Saishree Satyarupa

December 12, 2019
#MyPaperBagChallenge

Manas Samanta

December 12, 2019
#MyPaperBagChallenge

Pratyasharani Ghibela

December 12, 2019
#MyPaperBagChallenge

Jyotshna Mayee Pattnaik

December 12, 2019
#MyPaperBagChallenge

Swarit Praharaj

December 12, 2019

Archives

Editorial

Trouble For Iran

Iran flag
June 18, 2025

The escalating conflict between Israel and Iran has plunged the Middle East into deeper turmoil, with ramifications stretching far beyond...

Read more

Korean Challenge

Lee Jae-myung
June 17, 2025

The people of South Korea have shown their maturity as votaries of democracy by recently gifting a landslide victory to...

Read more

Mid East Great Again

Iran's private message to Israel: ‘Can intervene if military campaign continues in Gaza’
June 16, 2025

For decades, current Israeli Prime Minister Benjamin Netanyahu has been warning about the “existential threat” that a nuclear-armed Iran poses...

Read more

Nameless Doctrine

June 15, 2025

On 12 June, the United Nations General Assembly adopted a resolution demanding an immediate, unconditional and lasting ceasefire in Gaza....

Read more
  • Home
  • State
  • Metro
  • National
  • International
  • Business
  • Editorial
  • Opinion
  • Sports
  • About Us
  • Advertise
  • Contact Us
  • Jobs
Developed By Ratna Technology

© 2024 All rights Reserved by OrissaPOST

  • News in Odia
  • Orissa POST Epaper
  • Video
  • Home
  • Trending
  • Metro
  • State
  • Odisha Special
  • National
  • International
  • Sports
  • Business
  • Editorial
  • Entertainment
  • Horoscope
  • Careers
  • Feature
  • Today’s Pic
  • Opinion
  • Sci-Tech
  • About Us
  • Contact Us
  • Jobs

© 2024 All rights Reserved by OrissaPOST

    • News in Odia
    • Orissa POST Epaper
    • Video
    • Home
    • Trending
    • Metro
    • State
    • Odisha Special
    • National
    • International
    • Sports
    • Business
    • Editorial
    • Entertainment
    • Horoscope
    • Careers
    • Feature
    • Today’s Pic
    • Opinion
    • Sci-Tech
    • About Us
    • Contact Us
    • Jobs

    © 2024 All rights Reserved by OrissaPOST